| CTN |
NIDA-CTN-0054 |
Accelerated Development of Additive Pharmacotherapy Treatment for Methamphetamine Use Disorder (ADAPT) |
Walter Ling, M.D. |
|
| CTN |
NIDA-CTN-0048 |
Cocaine Use Reduction with Buprenorphine (CURB) |
Walter Ling, M.D. |
|
| CTN |
NIDA-CTN-0030 |
A Two-Phase Randomized Controlled Clinical Trial of Buprenorphine/Naloxone Treatment Plus Individual Drug Counseling for Opioid Analgesic Dependence |
Walter Ling, M.D., Roger Weiss, M.D. |
|
| CTN |
NIDA-CTN-0027 |
Starting Treatment with Agonist Replacement Therapies (START) |
Walter Ling, M.D. |
|
| CTN |
NIDA-CTN-0003 |
Suboxone (Buprenorphine/Naloxone) Taper: A Comparison of Two Schedules |
Walter Ling, M.D. |
|
| CTN |
NIDA-CTN-0002 |
Buprenorphine/Naloxone versus Clonidine for Outpatient Opiate Detoxification |
Walter Ling, M.D. |
|
| CTN |
NIDA-CTN-0001 |
Buprenorphine/Naloxone versus Clonidine for Inpatient Opiate Detoxification |
Walter Ling, M.D. |
|
| DTMC |
NIDA-CSP-1018 |
A Multicenter Safety Trial of Buprenorphine/Naloxone for the Treatment of Opiate Dependence |
Walter Ling, M.D., Paul J. Fudala, Ph.D., Paul Casadonte, M.D. |
|
| DTMC |
NIDA-CSP-999 |
A Multicenter Clinical Trial of Buprenorphine in Treatment of Opiate Dependence |
Walter Ling, M.D., Donald R. Wesson, M.D., C. James Klett, Ph.D. |
|
